BusinessProLynx announces SBIR grant award to develop novel technology for dual receptor agonistsBy Nasdaq OMXSep 25, 2017, 1:00 PM UTC
BusinessProLynx announces collaboration with Daiichi Sankyo to evaluate drug delivery system in the eyeBy Nasdaq OMXJun 19, 2017, 1:00 PM UTC